Hofland KF - Search Results

1

A systematic planning method to spare the rectal wall in radiotherapy of prostate cancer.

Jakobsen K, Kaplan LP, Marsguerra R, Bebek M, Hofland KF, Hinsby ES. Jakobsen K, et al. Among authors: hofland kf. Acta Oncol. 2023 Nov;62(11):1451-1454. doi: 10.1080/0284186X.2023.2252587. Epub 2023 Sep 15. Acta Oncol. 2023. PMID: 37712583 No abstract available.

2

Effect of bevacizumab on intracranial meningiomas in patients with neurofibromatosis type 2 - a retrospective case series.

Alanin MC, Klausen C, Caye-Thomasen P, Thomsen C, Fugleholm K, Poulsgaard L, Lassen U, Mau-Sorensen M, Hofland KF. Alanin MC, et al. Among authors: hofland kf. Int J Neurosci. 2016 Nov;126(11):1002-6. doi: 10.3109/00207454.2015.1092443. Epub 2015 Oct 6. Int J Neurosci. 2016. PMID: 26365467

3

The effect of bevacizumab on vestibular schwannoma tumour size and hearing in patients with neurofibromatosis type 2.

Alanin MC, Klausen C, Caye-Thomasen P, Thomsen C, Fugleholm K, Poulsgaard L, Lassen U, Mau-Sorensen M, Hofland KF. Alanin MC, et al. Among authors: hofland kf. Eur Arch Otorhinolaryngol. 2015 Dec;272(12):3627-33. doi: 10.1007/s00405-014-3398-3. Epub 2014 Nov 25. Eur Arch Otorhinolaryngol. 2015. PMID: 25421643

4

Neoadjuvant bevacizumab and irinotecan versus bevacizumab and temozolomide followed by concomitant chemoradiotherapy in newly diagnosed glioblastoma multiforme: A randomized phase II study.

Hofland KF, Hansen S, Sorensen M, Engelholm S, Schultz HP, Muhic A, Grunnet K, Ask A, Costa JC, Kristiansen C, Thomsen C, Poulsen HS, Lassen U. Hofland KF, et al. Acta Oncol. 2014 Jul;53(7):939-44. doi: 10.3109/0284186X.2013.879607. Epub 2014 Jan 23. Acta Oncol. 2014. PMID: 24456504 Clinical Trial.

5

The European medicines agency review of eribulin for the treatment of patients with locally advanced or metastatic breast cancer: summary of the scientific assessment of the committee for medicinal products for human use.

Pean E, Klaar S, Berglund EG, Salmonson T, Borregaard J, Hofland KF, Ersbøll J, Abadie E, Giuliani R, Pignatti F. Pean E, et al. Among authors: hofland kf. Clin Cancer Res. 2012 Sep 1;18(17):4491-7. doi: 10.1158/1078-0432.CCR-11-3075. Epub 2012 Jul 24. Clin Cancer Res. 2012. PMID: 22829199

6

A mouse model for studying the interaction of bisdioxopiperazines with topoisomerase IIalpha in vivo.

Grauslund M, Thougaard AV, Füchtbauer A, Hofland KF, Hjorth PH, Jensen PB, Sehested M, Füchtbauer EM, Jensen LH. Grauslund M, et al. Among authors: hofland kf. Mol Pharmacol. 2007 Oct;72(4):1003-14. doi: 10.1124/mol.107.036970. Epub 2007 Jul 10. Mol Pharmacol. 2007. PMID: 17622580

7

Indication of a role of plasminogen activator inhibitor type I in protecting murine fibrosarcoma cells against apoptosis.

Rømer MU, Kirkebjerg Due A, Knud Larsen J, Hofland KF, Christensen IJ, Buhl-Jensen P, Almholt K, Lerberg Nielsen O, Brünner N, Lademann U. Rømer MU, et al. Among authors: hofland kf. Thromb Haemost. 2005 Oct;94(4):859-66. Thromb Haemost. 2005. PMID: 16270643

8

Combining etoposide and dexrazoxane synergizes with radiotherapy and improves survival in mice with central nervous system tumors.

Hofland KF, Thougaard AV, Dejligbjerg M, Jensen LH, Kristjansen PE, Rengtved P, Sehested M, Jensen PB. Hofland KF, et al. Clin Cancer Res. 2005 Sep 15;11(18):6722-9. doi: 10.1158/1078-0432.CCR-05-0698. Clin Cancer Res. 2005. PMID: 16166453

9

Dexrazoxane protects against myelosuppression from the DNA cleavage-enhancing drugs etoposide and daunorubicin but not doxorubicin.

Hofland KF, Thougaard AV, Sehested M, Jensen PB. Hofland KF, et al. Clin Cancer Res. 2005 May 15;11(10):3915-24. doi: 10.1158/1078-0432.CCR-04-2343. Clin Cancer Res. 2005. PMID: 15897593

10

Malignant transformation of wild-type but not plasminogen activator inhibitor-1 gene-deficient fibroblasts decreases cellular sensitivity to chemotherapy-mediated apoptosis.

Lademann U, Rømer MU, Jensen PB, Hofland KF, Larsen L, Christensen IJ, Brünner N. Lademann U, et al. Among authors: hofland kf. Eur J Cancer. 2005 May;41(7):1095-100. doi: 10.1016/j.ejca.2005.02.010. Eur J Cancer. 2005. PMID: 15862760

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters